Coffee consumption and the occurrence and intensity of metabolic syndrome: a cross-sectional study

References

• Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, et al. 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Allam-Ndoul B, Guenard F, Garneau V, Cormier H, Barbier O, Perusse L, Vohl MC. 2016. Association between metabolite profiles, metabolic syndrome and obesity status. Nutrients. 8:324. doi: 10.3390/nu8060324.
   Web of Science ®Google Scholar
• Balk L, Hoekstra T, Twisk J. 2009. Relationship between long-term coffee consumption and components of the metabolic syndrome: the Amsterdam Growth and Health Longitudinal Study. Eur J Epidemiol. 24:203–209.
   PubMed Web of Science ®Google Scholar
• Dehghan M, Ilow R, Zatonska K, Szuba A, Zhang X, Mente A, Regulska-Ilow B. 2012. Development, reproducibility and validity of the food frequency questionnaire in the Poland arm of the Prospective Urban and Rural Epidemiological (PURE) study. J Hum Nutr Diet. 25:225–232.
   PubMed Web of Science ®Google Scholar
• Ding M, Bhupathiraju SN, Chen M, van Dam RM, Hu FB. 2014a. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care. 37:569–586.
   PubMed Web of Science ®Google Scholar
• Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. 2014b. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 129:643–659.
   PubMed Web of Science ®Google Scholar
• Ding M, Satija A, Bhupathiraju SN, Hu Y, Sun Q, Han J, Lopez-Garcia E, Willett W, van Dam RM, Hu FB. 2015. Association of coffee consumption with total and cause-specific mortality in 3 large prospective cohorts. Circulation. 132:2305–2315.
   PubMed Web of Science ®Google Scholar
• Driessen MT, Koppes LL, Veldhuis L, Samoocha D, Twisk JW. 2009. Coffee consumption is not related to the metabolic syndrome at the age of 36 years: the Amsterdam Growth and Health Longitudinal Study. Eur J Clin Nutr. 63:536–542.
   PubMed Web of Science ®Google Scholar
• Gavrieli A, Karfopoulou E, Kardatou E, Spyreli E, Fragopoulou E, Mantzoros CS, Yannakoulia M. 2013. Effect of different amounts of coffee on dietary intake and appetite of normal-weight and overweight/obese individuals. Obesity (Silver Spring). 21:1127–1132.
   PubMed Web of Science ®Google Scholar
• Greenberg JA, Axen KV, Schnoll R, Boozer CN. 2005. Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes (Lond). 29:1121–1129.
   PubMed Web of Science ®Google Scholar
• Grosso G, Marventano S, Galvano F, Pajak A, Mistretta A. 2014. Factors associated with metabolic syndrome in a Mediterranean population: role of caffeinated beverages. J Epidemiol. 24:327–333.
   PubMed Web of Science ®Google Scholar
• Grosso G, Stepaniak U, Micek A, Topor-Madry R, Pikhart H, Szafraniec K, Pajak A. 2015. Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr. 54:1129–1137.
   PubMed Web of Science ®Google Scholar
• Hedstrom AK, Mowry EM, Gianfrancesco MA, Shao X, Schaefer CA, Shen L, Olsson T, Barcellos LF, Alfredsson L. 2016. High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies. J Neurol Neurosurg Psychiatry. 87:454–460.
   PubMed Web of Science ®Google Scholar
• Hino A, Adachi H, Enomoto M, Furuki K, Shigetoh Y, Ohtsuka M, Kumagae S, Hirai Y, Jalaldin A, Satoh A, et al. 2007. Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res Clin Pract. 76:383–389.
   PubMed Web of Science ®Google Scholar
• Jee SH, He J, Whelton PK, Suh I, Klag MJ. 1999. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension. 33:647–652.
   PubMed Web of Science ®Google Scholar
• Jiang X, Zhang D, Jiang W. 2014. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr. 53:25–38.
   PubMed Web of Science ®Google Scholar
• Lee AH, Tan L, Hiramatsu N, Ishisaka A, Alfonso H, Tanaka A, Uemura N, Fujiwara Y, Takechi R. 2016. Plasma concentrations of coffee polyphenols and plasma biomarkers of diabetes risk in healthy Japanese women. Nutr Diabetes. 6:e212. doi: 10.1038/nutd.2016.19.
   PubMed Web of Science ®Google Scholar
• Lutsey PL, Steffen LM, Stevens J. 2008. Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation. 117:754–761.
   PubMed Web of Science ®Google Scholar
• Marventano S, Salomone F, Godos J, Pluchinotta F, Del Rio D, Mistretta A, Grosso G. 2016. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: a systematic review and meta-analysis of observational studies. Clin Nutr. 35:1269–1281.
   PubMed Web of Science ®Google Scholar
• Matsuura H, Mure K, Nishio N, Kitano N, Nagai N, Takeshita T. 2012. Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. J Epidemiol. 22:160–166.
   PubMed Web of Science ®Google Scholar
• Meng S, Cao J, Feng Q, Peng J, Hu Y. 2013. Roles of chlorogenic acid on regulating glucose and lipids metabolism: a review. Evid Based Complement Alternat Med. 2013:801457. doi: 10.1155/2013/801457.
   PubMed Web of Science ®Google Scholar
• Neary MT, Batterham RL. 2009. Gut hormones: implications for the treatment of obesity. Pharmacol Ther. 124:44–56.
   PubMed Web of Science ®Google Scholar
• Nordestgaard AT, Thomsen M, Nordestgaard BG. 2015. Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study. Int J Epidemiol. 44:551–565.
   PubMed Web of Science ®Google Scholar
• O'Keefe JH, Bhatti SK, Patil HR, DiNicolantonio JJ, Lucan SC, Lavie CJ. 2013. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol. 62:1043–1051.
   PubMed Web of Science ®Google Scholar
• Pimentel VR, de Sousa MF, Hamann EM, Mendonca AV. 2014. Food and nutrition in the family health strategy in five Brazilian cities. Cien Saude Colet. 19:49–57.
   PubMed Web of Science ®Google Scholar
• Qi H, Li S. 2014. Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease. Geriatr Gerontol Int. 14:430–439.
   PubMed Web of Science ®Google Scholar
• Ran HQ, Wang JZ, Sun CQ. 2016. Coffee consumption and pancreatic cancer risk: an update meta-analysis of cohort studies. Pak J Med Sci. 32:253–259.
   PubMed Web of Science ®Google Scholar
• Reaven G, Abbasi F, McLaughlin T. 2004. Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res. 59:207–223.
   PubMedGoogle Scholar
• Saleh D, Janssen I. 2014. Interrelationships among sedentary time, sleep duration, and the metabolic syndrome in adults. BMC Public Health. 14:666. doi: 10.1186/1471-2458-14-666.
   PubMed Web of Science ®Google Scholar
• Schmit SL, Rennert HS, Rennert G, Gruber SB. 2016. Coffee consumption and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 25:634–639.
   PubMed Web of Science ®Google Scholar
• Setiawan VW, Wilkens LR, Lu SC, Hernandez BY, Le Marchand L, Henderson BE. 2015. Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort. Gastroenterology. 148:118–125; quiz e115.
   PubMed Web of Science ®Google Scholar
• Shang F, Li X, Jiang X. 2016. Coffee consumption and risk of the metabolic syndrome: a meta-analysis. Diabetes Metab. 42:80–87.
   PubMed Web of Science ®Google Scholar
• Suliga E, Koziel D, Ciesla E, Gluszek S. 2015. Association between dietary patterns and metabolic syndrome in individuals with normal weight: a cross-sectional study. Nutr J. 14:55. doi: 10.1186/s12937-015-0045-9.
   PubMed Web of Science ®Google Scholar
• Takami H, Nakamoto M, Uemura H, Katsuura S, Yamaguchi M, Hiyoshi M, Sawachika F, Juta T, Arisawa K. 2013. Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan. J Epidemiol. 23:12–20.
   PubMed Web of Science ®Google Scholar
• Wilson PW, Bloom HL. 2016. Caffeine consumption and cardiovascular risks: little cause for concern. J Am Heart Assoc. 5:e003089. doi: 10.1161/JAHA.115.003089.
   PubMed Web of Science ®Google Scholar
• Zak-Golab A, Kocelak P, Aptekorz M, Zientara M, Juszczyk L, Martirosian G, Chudek J, Olszanecka-Glinianowicz M. 2013. Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int J Endocrinol. 2013:674106. doi: 10.1155/2013/674106.
   PubMed Web of Science ®Google Scholar
• Zamora-Ros R, Forouhi NG, Sharp SJ, Gonzalez CA, Buijsse B, Guevara M, van der Schouw YT, Amiano P, Boeing H, Bredsdorff L, et al. 2014. Dietary intakes of individual flavanols and flavonols are inversely associated with incident type 2 diabetes in European populations. J Nutr. 144:335–343.
   PubMed Web of Science ®Google Scholar
• Zatonski WA, Manczuk M, Kielce Pt. 2011. POlish-Norwegian Study (PONS): research on chronic non-communicable diseases in European high risk countries – study design. Ann Agric Environ Med. 18:203–206.
   PubMed Web of Science ®Google Scholar